4//SEC Filing
KARBE FRANK 4
Accession 0000899243-22-025715
CIK 0001832415other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:32 PM ET
Size
5.7 KB
Accession
0000899243-22-025715
Insider Transaction Report
Form 4
KARBE FRANK
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-07-05+472,200→ 472,200 totalExercise: $1.68Exp: 2032-07-04→ Common Stock (472,200 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/4 of the shares subject to the stock option on July 5, 2023 and the remaining shares vest in 36 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on July 5, 2022.
Documents
Issuer
Better Therapeutics, Inc.
CIK 0001832415
Entity typeother
Related Parties
1- filerCIK 0001276700
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:32 PM ET
- Size
- 5.7 KB